CA3034136A1 - Saposin lipoprotein particles and libraries from crude membranes - Google Patents
Saposin lipoprotein particles and libraries from crude membranes Download PDFInfo
- Publication number
- CA3034136A1 CA3034136A1 CA3034136A CA3034136A CA3034136A1 CA 3034136 A1 CA3034136 A1 CA 3034136A1 CA 3034136 A CA3034136 A CA 3034136A CA 3034136 A CA3034136 A CA 3034136A CA 3034136 A1 CA3034136 A1 CA 3034136A1
- Authority
- CA
- Canada
- Prior art keywords
- membrane
- particles
- protein
- cell
- saposin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0012—Lipids; Lipoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16184843.7A EP3284460A1 (en) | 2016-08-19 | 2016-08-19 | Saposin lipoprotein particles and libraries from crude membranes |
| EP16184843.7 | 2016-08-19 | ||
| PCT/EP2017/071043 WO2018033647A1 (en) | 2016-08-19 | 2017-08-21 | Saposin lipoprotein particles and libraries from crude membranes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3034136A1 true CA3034136A1 (en) | 2018-02-22 |
Family
ID=56740926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3034136A Pending CA3034136A1 (en) | 2016-08-19 | 2017-08-21 | Saposin lipoprotein particles and libraries from crude membranes |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11346843B2 (enExample) |
| EP (2) | EP3284460A1 (enExample) |
| JP (3) | JP7149929B2 (enExample) |
| CN (1) | CN109640960B (enExample) |
| CA (1) | CA3034136A1 (enExample) |
| DK (1) | DK3463303T3 (enExample) |
| ES (1) | ES2797257T3 (enExample) |
| PT (1) | PT3463303T (enExample) |
| WO (1) | WO2018033647A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3725304A1 (en) * | 2019-04-15 | 2020-10-21 | Salipro Biotech AB | Production of salipro particles |
| CN110483618B (zh) * | 2019-09-11 | 2022-09-09 | 青岛科技大学 | 杂[4]芳烃衍生物及其制备和应用 |
| CN111040019B (zh) * | 2019-12-25 | 2022-06-07 | 上海交通大学 | 一种用于与TfR蛋白特异性结合的配体多肽及其应用 |
| CA3197426A1 (en) | 2020-12-23 | 2022-06-30 | Regeneron Pharmaceuticals, Inc. | Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same |
| US20220268785A1 (en) * | 2021-02-19 | 2022-08-25 | Northwestern University | Facile sample preparation for quantitative single-cell proteomics |
| JP7808617B2 (ja) * | 2021-03-31 | 2026-01-29 | ユニヴェルシテ・グルノーブル・アルプ | ナノ構造生体模倣ニューロモルフィックシステム |
| EP4123307A1 (en) | 2021-07-22 | 2023-01-25 | Salipro Biotech AB | Methods for structure determination and drug design using salipro particles |
| WO2023001912A1 (en) | 2021-07-22 | 2023-01-26 | Salipro Biotech AB | Methods for structure determination and drug design using salipro particles |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6872406B2 (en) * | 2000-02-11 | 2005-03-29 | Children's Hospital Research Foundation | Fusogenic properties of saposin C and related proteins and polypeptides for application to transmembrane drug delivery systems |
| CN1474831A (zh) | 2000-11-20 | 2004-02-11 | ����ŵ˹������ѧ�йܻ� | 膜支架蛋白 |
| WO2004073684A2 (en) | 2003-02-14 | 2004-09-02 | Children's Hospital & Research Center At Oakland | Lipophilic drug delivery vehicle and methods of use thereof |
| CN103585105A (zh) * | 2008-11-07 | 2014-02-19 | 儿童医院医疗中心 | 用于跨膜药物递送系统的鞘脂激活蛋白c以及相关蛋白和肽促融合性质 |
| GB0913823D0 (en) | 2009-08-07 | 2009-09-16 | Isis Innovation | Bilayers |
| ES2608857T3 (es) * | 2012-12-18 | 2017-04-17 | Salipro Biotech Ag | Partículas Salipro |
| LT3043814T (lt) | 2013-09-13 | 2021-02-25 | Salipro Biotech AB | Antigenas ir jo gamybos būdas |
-
2016
- 2016-08-19 EP EP16184843.7A patent/EP3284460A1/en not_active Withdrawn
-
2017
- 2017-08-21 PT PT177554979T patent/PT3463303T/pt unknown
- 2017-08-21 ES ES17755497T patent/ES2797257T3/es active Active
- 2017-08-21 CN CN201780050737.6A patent/CN109640960B/zh active Active
- 2017-08-21 WO PCT/EP2017/071043 patent/WO2018033647A1/en not_active Ceased
- 2017-08-21 CA CA3034136A patent/CA3034136A1/en active Pending
- 2017-08-21 JP JP2019509544A patent/JP7149929B2/ja active Active
- 2017-08-21 EP EP17755497.9A patent/EP3463303B1/en active Active
- 2017-08-21 DK DK17755497.9T patent/DK3463303T3/da active
- 2017-08-21 US US16/326,545 patent/US11346843B2/en active Active
-
2022
- 2022-07-22 JP JP2022116793A patent/JP7460700B2/ja active Active
-
2024
- 2024-03-21 JP JP2024044505A patent/JP7702167B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7702167B2 (ja) | 2025-07-03 |
| US20190204337A1 (en) | 2019-07-04 |
| US11346843B2 (en) | 2022-05-31 |
| EP3463303B1 (en) | 2020-03-11 |
| WO2018033647A1 (en) | 2018-02-22 |
| EP3463303A1 (en) | 2019-04-10 |
| JP7149929B2 (ja) | 2022-10-07 |
| ES2797257T3 (es) | 2020-12-01 |
| DK3463303T3 (da) | 2020-06-15 |
| PT3463303T (pt) | 2020-06-18 |
| JP7460700B2 (ja) | 2024-04-02 |
| JP2024096708A (ja) | 2024-07-17 |
| CN109640960A (zh) | 2019-04-16 |
| CN109640960B (zh) | 2022-08-12 |
| EP3284460A1 (en) | 2018-02-21 |
| JP2019529360A (ja) | 2019-10-17 |
| JP2022163077A (ja) | 2022-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11346843B2 (en) | Saposin lipoprotein particles and libraries from crude membranes | |
| JP6293779B2 (ja) | Ｓａｌｉｐｒｏ粒子 | |
| Ichimura et al. | In vivo and in vitro reconstitution of Atg8 conjugation essential for autophagy | |
| US12383501B2 (en) | Production of salipro particles | |
| Justesen et al. | Active plasma membrane P-type H+-ATPase reconstituted into nanodiscs is a monomer | |
| US20220270707A1 (en) | Saposin lipoprotein particles and libraries from crude membranes | |
| CA3136842C (en) | Production of salipro particles | |
| CN116500119A (zh) | 一种对样本中囊泡提取效率质控的方法 | |
| van ‘t Klooster et al. | Periprotein membrane lipidomics and the role of lipids in transporter function in yeast | |
| Frick | Establishing membrane mimetics for the mass spectrometric analysis of membrane proteins | |
| Mateo et al. | From lipid phases to membrane protein organization: fluorescence methodologies in the study of lipid-protein interactions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220704 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - STANDARD Year of fee payment: 7 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240724 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20240805 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20241119 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250122 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250122 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250130 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250527 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250527 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD Year of fee payment: 8 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250724 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250724 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT Effective date: 20251209 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251224 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D164 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: RESPONSE TO NOTICE OF ALLOWANCE Effective date: 20260203 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-4-D10-D22-D143 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRE-GRANT Effective date: 20260423 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260423 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 9TH ANNIV.) - STANDARD Year of fee payment: 9 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260716 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260716 |